Medtronic Management

Management criteria checks 3/4

Medtronic's CEO is Geoff Martha, appointed in Apr 2020, has a tenure of 3.25 years. total yearly compensation is $16.85M, comprised of 8% salary and 92% bonuses, including company stock and options. directly owns 0.002% of the company’s shares, worth $2.64M. The average tenure of the management team and the board of directors is 3.3 years and 8.5 years respectively.

Key information

Geoff Martha

Chief executive officer

US$16.8m

Total compensation

CEO salary percentage8.0%
CEO tenure3.3yrs
CEO ownership0.002%
Management average tenure3.3yrs
Board average tenure8.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Geoff Martha's remuneration changed compared to Medtronic's earnings?
DateTotal CompensationSalaryCompany Earnings
Apr 28 2023n/an/a

US$4b

Jan 27 2023n/an/a

US$4b

Oct 28 2022n/an/a

US$4b

Jul 29 2022n/an/a

US$5b

Apr 29 2022n/an/a

US$5b

Jan 28 2022n/an/a

US$5b

Oct 29 2021n/an/a

US$5b

Jul 30 2021n/an/a

US$4b

Apr 30 2021US$16mUS$1m

US$4b

Jan 29 2021n/an/a

US$3b

Oct 30 2020n/an/a

US$4b

Jul 31 2020n/an/a

US$4b

Apr 24 2020US$6mUS$905k

US$5b

Jan 24 2020n/an/a

US$5b

Oct 25 2019n/an/a

US$5b

Jul 26 2019n/an/a

US$4b

Apr 26 2019US$4mUS$693k

US$5b

Compensation vs Market: Geoff's total compensation ($USD16.85M) is above average for companies of similar size in the AR market ($USD5.70M).

Compensation vs Earnings: Geoff's compensation has been consistent with company performance over the past year.


CEO

Geoff Martha (53 yo)

3.3yrs

Tenure

US$16,849,633

Compensation

Mr. Geoffrey Straub Martha, also known as Geoff, serves as Director at Medtronic plc since November 01, 2019 and serves as its Chief Executive Officer since April 27, 2020. He serves as Chairman at Medtron...


Leadership Team

NamePositionTenureCompensationOwnership
Geoffrey Martha
Chairman of the Board & CEO3.3yrsUS$16.85m0.0023%
$ 2.6m
Karen Parkhill
Executive VP & CFO7.1yrsUS$7.14m0.00025%
$ 289.8k
Ivan Fong
Executive VP1.4yrsUS$11.72m0.00057%
$ 660.8k
Robert J. ten Hoedt
Executive VP & President of Global Regions8.5yrsUS$5.66m0.0033%
$ 3.8m
Robert White
Executive VP & President of Medical Surgical Portfolio8.5yrsUS$6.03m0.0012%
$ 1.4m
Mark Ploof
Senior Vice President of Global Operations and Business Services6.8yrsno datano data
Jennifer Kirk
Senior VP2.1yrsno data0.00076%
$ 881.1k
Kenneth Washington
Senior VP and Chief Technology & Innovation Officerless than a yearno datano data
Laura Mauri
Senior VP and Chief Scientific1.3yrsno datano data
Ryan Weispfenning
VP & Head of Investor Relations8.1yrsno datano data
Torod Neptune
Senior VP & Chief Communications Officer2.5yrsno datano data
Sean Salmon
Executive VP & President of Cardiovascular Portfoliono datano data0.0013%
$ 1.5m

3.3yrs

Average Tenure

59yo

Average Age

Experienced Management: MDTD's management team is considered experienced (3.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Geoffrey Martha
Chairman of the Board & CEO3.7yrsUS$16.85m0.0023%
$ 2.6m
Scott Donnelly
Independent Director10.5yrsUS$402.83k0.00096%
$ 1.1m
Kendall Powell
Independent Director16.5yrsUS$350.03k0.0014%
$ 1.6m
Randall Hogan
Independent Director8.5yrsUS$376.63k0.0031%
$ 3.6m
Richard Anderson
Independent Director21.5yrsUS$365.03k0.0065%
$ 7.6m
Craig Arnold
Lead Independent Director8.5yrsUS$376.43k0.0026%
$ 3.0m
Denise O'Leary
Independent Director23.5yrsUS$370.83k0.0053%
$ 6.2m
Andrea Goldsmith
Independent Director4.3yrsUS$353.23k0.00032%
$ 371.0k
Elizabeth Nabel
Independent Director9.5yrsUS$382.63k0.00088%
$ 1.0m
Lidia Fonseca
Independent Director1.1yrsno datano data
Kevin Lofton
Independent Director2.8yrsUS$365.83k0.00017%
$ 197.1k

8.5yrs

Average Tenure

65yo

Average Age

Experienced Board: MDTD's board of directors are considered experienced (8.5 years average tenure).